Sinohealth Technology Holdings Ltd. has announced its 2025 AI commercialization business update. The company plans to advance the commercialization of AI large models and AI agents, with a focus on expanding its AI services and products across various application scenarios. These include marketing, healthcare, pharmacies, and consumer management. Sinohealth aims to strengthen its cooperation network within the healthcare industry, covering physicians, pharmacies, and patients. The company emphasizes that these developments are based on preliminary assessments and available information, and advises shareholders and investors to exercise caution.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinohealth Technology Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251224-11966972), on December 24, 2025, and is solely responsible for the information contained therein.